BioJapan is "Asia's largest partnering event consisting of Exhibition, Seminar, and Partnering program". Dr Jorg Taubel and Dr Ulrike Lorch look forward to attending in-person once again this year. 

This event incorporates three exhibitions.

1. The world's oldest biotechnology exhibition "BioJapan" (1986-),

2. "Regenerative Medicine JAPAN" (2016-), aiming to accelerate and industrialize R&D in the field of regenerative medicine including iPS cells, and 

3."health TECH JAPAN"(2020-), provides fusion of digital technology and life science.

The event focusses on providing new value by business partnering of industry, academia, and government which is not limited to Japan, but also from overseas.

Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event